Abbott India Est. EPS Q / Q
¿Qué es el Est. EPS Q / Q de Abbott India?
El Est. EPS Q / Q de Abbott India Limited es N/A
¿Cuál es la definición de Est. EPS Q / Q?
La tasa de crecimiento prospectiva trimestral del EPS, año tras año, es el aumento estimado del EPS de la compañía para el próximo trimestre en comparación con el comportamiento de un trimestre correspondiente anterior.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
¿Qué hace Abbott India?
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.